ETHK Labs Inc
01931
Company Profile
Business description
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
Contact
Lane 299, Bisheng Road
Room 602, Building 6, Zhangjiang Hi-Tech Park
Pudong New Area District
Shanghai
CHNSector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
910
Stocks News & Analysis
stocks
Avoid this overvalued ASX lithium producer
Why the market may be overpricing future earnings for this lithium producer.
stocks
Morningstar's verdict on SpaceX
Mark and Shani run through the business and what our analysts think about the IPO.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,012.60 | 10.70 | 0.12% |
| CAC 40 | 8,369.24 | 28.53 | 0.34% |
| DAX 40 | 24,629.29 | 264.29 | -1.06% |
| Dow JONES (US) | 51,703.65 | 36.81 | 0.07% |
| FTSE 100 | 10,436.79 | 7.94 | 0.08% |
| HKSE | 23,412.18 | 75.90 | 0.33% |
| NASDAQ | 25,636.60 | 49.56 | 0.19% |
| Nikkei 225 | 69,174.97 | 613.41 | -0.88% |
| NZX 50 Index | 13,400.66 | 35.11 | -0.26% |
| S&P 500 | 7,384.33 | 18.87 | 0.26% |
| S&P/ASX 200 | 8,808.40 | 7.00 | 0.08% |
| SSE Composite Index | 4,110.81 | 4.56 | 0.11% |